A Study to Measure Baricitinib (LY3009104) Absorption in Healthy Participants

Clinical trial NCT02340104 · COMPLETED

Trial details

NCT number: NCT02340104
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2015-01-01
Primary completion: 2015-02-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.